Clinical breast cancer
Evaluating the Efficacy and Safety of NEOadjuvant CHEmoimmunotherapy in Early ER-Low/HER2-Negative Breast Cancer (NEOCHEER): A Systematic Review and Meta-Analysis.
Jessé Lopes da Silva, Luís Felipe Leite da Silva, Wallace Klein Schwengber, Lucas Zanetti de Albuquerque, Natália Cristina Cardoso Nunes, Andréia Cristina de Melo
Published: 202510.1016/j.clbc.2025.09.017
Abstract
To evaluate the efficacy and safety of neoadjuvant chemoimmunotherapy in patients with early-stage estrogen receptor (ER)-low/HER2-negative breast cancer (BC), a population often overlooked in clinical trials. A systematic review and meta-analysis we…
Preview only. Read the full abstract at the source